HLA-E and Miyoshi myopathy: To better investigate the possible correlation between cell-cycle status and HLA-E expression, we explored the efficacy of IMiDs chemotherapeutic agents (e.g., Lenalidomide) in combination with CX-5461, given their reported capability to induce growth arrest and preferential enrichment in G1 phase of MM cells [71].